Publication | Closed Access
Anti-tumor effects of anti-PD-1 antibody, pembrolizumab, in humanized NSG PDX mice xenografted with dedifferentiated liposarcoma
44
Citations
29
References
2020
Year
MedicineImmunologyImmune Checkpoint InhibitorTumor TargetingAnti-cancer AgentAnti-pd-1 AntibodyCancer TreatmentNsg Pdx MiceImmunotherapyRadiation OncologyTumor BiologyDedifferentiated Liposarcoma
| Year | Citations | |
|---|---|---|
Page 1
Page 1